Journal article icon

Journal article

Assessing treatment adherence is crucial to determine adequacy of mineralocorticoid therapy

Abstract:
Background: There is no consensus strategy for mineralocorticoid (MC) therapy titration in patients with primary adrenal insufficiency (PAI). W e aim to measure serum fludrocortisone (sFC) and urine fludrocortisone (uFC) levels and to determine their utility, alongside clinical/biochemical variables and treatment adherence to guide MC replacement dose titration. Methods: Multi-centre, observational, cross-sectional study on 41 patients with PAI on MC replacement therapy. sFC and uFC levels (measured by liquid chr omatography-tandem mass spectrometry), plasma renin concentration (PRC), electrolytes (Na+, K+), mean arterial blood pressure (MAP), total daily glucocorticoid (dGC) and MC (dMC) dose, and assessment of treatment adherence were incorporated into statis tical models. Results: We observed a close relationship between sFC and uFC ( r = 0.434, P = 0.005) and between sFC and the time from the last fludrocortisone dose ( r = −0.355, P = 0.023). Total dMC dose was related to dGC dose ( r = 0.556, P < 0.001), K+ (r = −0.388, P = 0.013) as well as sFC (r = 0.356, P = 0.022) and uFC (r = 0.531, P < 0.001). PRC was related to Na+ (r = 0.517, P < 0.001) and MAP (r = −0.427, P = 0.006), but not to MC dose, sFC or uFC. Regression analyses did not support a role for sFC, uFC or PRC measurements and confirmed K+ (B = −44.593, P = 0.005) as the most important variable to guide dMC titration. Of the patients, 32% were non-adherent with replacem ent therapy. When adherence was inserted into the regression model, it was the on ly factor affecting dMC. Conclusions: sFC and uFC levels are not helpful in guiding dMC titration. T reatment adherence impacts on clinical variables used to assess MC replacement and should be included as part of routine care in patients with PAI
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-7808-5735
More by this author
Role:
Author
ORCID:
0000-0002-9333-5189
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-1016-8638


Publisher:
BioScientifica
Journal:
Endocrine Connections More from this journal
Volume:
12
Issue:
9
Pages:
e230059
Publication date:
2023-06-15
DOI:
ISSN:
2049-3614


Language:
English
Keywords:
Pubs id:
1492448
Local pid:
pubs:1492448
Source identifiers:
W4383302736
Deposit date:
2026-05-11
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP